Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan 18:9:742.
doi: 10.3389/fpsyt.2018.00742. eCollection 2018.

Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine

Affiliations
Review

Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine

Florence Noble et al. Front Psychiatry. .

Abstract

With the opioid crisis in North America, opioid addiction has come in the spotlight and reveals the weakness of the current treatments. Two main opioid substitution therapies (OST) exist: buprenorphine and methadone. These two molecules are mu opioid receptor agonists but with different pharmacodynamic and pharmacokinetic properties. In this review, we will go through these properties and see how they could explain why these medications are recognized for their efficacy in treating opioid addiction but also if they could account for the side effects especially for a long-term use. From this critical analysis, we will try to delineate some guidelines for the design of future OST.

Keywords: addiction; buprenorphine; methadone; morphine; substitution treatment.

PubMed Disclaimer

References

    1. Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health (2009) 99:221–7. 10.2105/AJPH.2007.131714 - DOI - PMC - PubMed
    1. Morone NE, Weiner DK. Pain as the fifth vital sign: exposing the vital need for pain education. Clin Ther. (2013) 35:1728–32. 10.1016/j.clinthera.2013.10.001 - DOI - PMC - PubMed
    1. Maremmani I, Gerra G. Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment. Am J Addict. (2010) 19:557–68. 10.1111/j.1521-0391.2010.00086.x - DOI - PubMed
    1. Dhawan BN, Cesselin F, Raghubir R, Reisine T, Bradley PB, Portoghese PS, et al. . International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev. (1996) 48:567–92. - PubMed
    1. Kieffer BL. Opioids: first lessons from knockout mice. Trends Pharmacol Sci. (1999) 20:19–26. 10.1016/S0165-6147(98)01279-6 - DOI - PubMed